3-Nitrotyrosine Modified Proteins in Atherosclerosis

Abstract EN

Cardiovascular disease is the leading cause of premature death worldwide, and atherosclerosis is the main contributor.

Lipid-laden macrophages, known as foam cells, accumulate in the subendothelial space of the lesion area and contribute to consolidate a chronic inflammatory environment where oxygen and nitrogen derived oxidants are released.

Oxidatively modified lipids and proteins are present both in plasma as well as atherosclerotic lesions.

A relevant oxidative posttranslational protein modification is the addition of a nitro group to the hydroxyphenyl ring of tyrosine residues, mediated by nitric oxide derived oxidants.

Nitrotyrosine modified proteins were found in the lesion and also in plasma from atherosclerotic patients.

Despite the fact of the low yield of nitration, immunogenic, proatherogenic, and prothrombotic properties acquired by 3-nitrotyrosine modified proteins are in agreement with epidemiological studies showing a significant correlation between the level of nitration found in plasma proteins and the prevalence of cardiovascular disease, supporting the usefulness of this biomarker to predict the outcome and to take appropriate therapeutic decisions in atherosclerotic disease.